financetom
Business
financetom
/
Business
/
Plus Therapeutics Gets Additional Time to Regain Compliance With Nasdaq Listing Requirement
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Plus Therapeutics Gets Additional Time to Regain Compliance With Nasdaq Listing Requirement
Nov 4, 2024 12:17 PM

01:01 PM EDT, 11/01/2024 (MT Newswires) -- Plus Therapeutics ( PSTV ) said in a regulatory filing Friday that a Nasdaq Hearings panel granted it until March 4, 2025 to regain compliance with the exchange's listing requirement for minimum shareholders' equity.

Shares were up over 6% in recent trading.

Price: 1.36, Change: +0.08, Percent Change: +6.56

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Walmart-backed Ibotta valued at $3.55 billion in robust market debut
Walmart-backed Ibotta valued at $3.55 billion in robust market debut
Apr 18, 2024
(Reuters) - Digital marketing firm Ibotta ( IBTA ) notched a valuation of $3.55 billion in its market debut on Thursday, after shares of the Walmart ( WMT )-backed company jumped 33% at open on the NYSE. ...
Update: Market Chatter: Microsoft's Investment in OpenAI Could Face Antitrust Investigation in EU
Update: Market Chatter: Microsoft's Investment in OpenAI Could Face Antitrust Investigation in EU
Apr 18, 2024
01:01 PM EDT, 04/18/2024 (MT Newswires) -- (Updates with Microsoft ( MSFT ) declines to comment in the fourth paragraph.) Microsoft's ( MSFT ) $13 billion investment in OpenAI could face an antitrust investigation as regulators in the EU are building a case for such scrutiny, Reuters reported Thursday, citing unnamed sources. The EU antitrust regulator had decided not to...
Why Is Gene Therapy Developer Benitec Biopharma Stock Trading Higher On Thursday?
Why Is Gene Therapy Developer Benitec Biopharma Stock Trading Higher On Thursday?
Apr 18, 2024
Thursday, Benitec Biopharma Inc ( BNTC ) released interim clinical data from the 90-day timepoint following the administration of BB-301 to the study’s first subject (Subject 1) treated in the BB-301 Phase 1b/2a study in Oculopharyngeal Muscular Dystrophy (OPMD). “To date, no clinical studies have systematically demonstrated a clinical improvement in OPMD patients across both objective and subjective measures of swallowing. We are, therefore,...
Infosys Posts Surprise Quarterly Earnings Growth, Agrees to Acquire German Auto Services Provider In-Tech
Infosys Posts Surprise Quarterly Earnings Growth, Agrees to Acquire German Auto Services Provider In-Tech
Apr 18, 2024
12:50 PM EDT, 04/18/2024 (MT Newswires) -- Infosys ( INFY ) reported a surprise gain in fiscal fourth-quarter earnings on Thursday despite virtually flat revenue while announcing an acquisition of a German automotive services provider. GAAP earnings per share increased to $0.23 for the three months ended March 31 from $0.18 a year ago, outperforming expectations in a Capital IQ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved